- Author:
Young Ah KIM
1
;
John Hoon RIM
;
Min Hyuk CHOI
;
Heejung KIM
;
Kyungwon LEE
Author Information
- Publication Type:Original Article
- Keywords: Clostridium difficile toxin B; Community-acquired infection; Epidemiology
- MeSH: Clostridium difficile*; Clostridium*; Community-Acquired Infections; Delivery of Health Care; Electronic Health Records; Epidemiology; Europe; Humans; Immunoassay; Infection Control; Korea; North America; Outpatients; Polymerase Chain Reaction; Public Health*
- From:Annals of Clinical Microbiology 2016;19(1):7-12
- CountryRepublic of Korea
- Language:Korean
- Abstract: BACKGROUND: Increasing rates of Clostridium difficile infection (CDI) have been reported mainly in Europe and North America; however, only limited reports have originated in Korea. The current epidemiology of CDI in the community could help to understand the outpatient healthcare environment and to extend infection control measures to outpatient settings. METHODS: C. difficile isolates in NHIS Ilsan Hospital from 2012 to 2014 were included in this study. Clinical characteristics, acquisition types, and previous antimicrobial therapy were obtained via Electronic Medical Records. C. difficile culture was performed only in unformed stool. Toxin was positive by enzyme-linked fluorescent immunoassay (ELFA) in 247 specimens. In addition, toxin B and binary toxin gene were detected by PCR in 57 specimens. CDI was defined by toxigenic C. difficile isolation in unformed stool. RESULTS: In the previous 3 years, 251 unduplicated C. difficile cases have been detected; 168 healthcare facility- associated hospital onset (HCFA-HO), 45 healthcare facility-associated community onset (HCFA-CO), and 38 community-associated (CA). Toxin positive rates by ELFA for toxin A&B were HCFA-HO 50.6% (84/166), HCFA-CO 41.9% (18/43), and CA 42.1% (16/38). Toxin positive rate by PCR for tcdB were HCFA-HO 62.9% (22/35), HCFA-CO 69.2% (9/13), and CA 100% (9/9). No binary toxin (cdtA/cdtB) was detected in 57 cases. CONCLUSION: Community-associated CDI may be underestimated in Goyang province, Korea, especially by commonly used ELFA toxin assay. The spread of community-associated CDI should be recognized as an increasing burden of public health.